pubmed-article:6086401 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:6086401 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
pubmed-article:6086401 | lifeskim:mentions | umls-concept:C0229671 | lld:lifeskim |
pubmed-article:6086401 | lifeskim:mentions | umls-concept:C0205054 | lld:lifeskim |
pubmed-article:6086401 | lifeskim:mentions | umls-concept:C0017968 | lld:lifeskim |
pubmed-article:6086401 | lifeskim:mentions | umls-concept:C0023206 | lld:lifeskim |
pubmed-article:6086401 | lifeskim:mentions | umls-concept:C0243144 | lld:lifeskim |
pubmed-article:6086401 | lifeskim:mentions | umls-concept:C1549781 | lld:lifeskim |
pubmed-article:6086401 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:6086401 | pubmed:dateCreated | 1984-9-17 | lld:pubmed |
pubmed-article:6086401 | pubmed:abstractText | Human serum will inhibit the specific uptake of N-acetylglucosamine-terminated glycoproteins by isolated rat hepatic sinusoidal cells. The serum inhibitors are not glycoproteins that bind to the hepatic mannose/N-acetylglucosamine receptor but have the properties of lectins which bind to mannose/N-acetylglucosamine-terminated glycoproteins. They can be isolated from serum by affinity chromatography. The predominant lectin, with a molecular mass of less than 35 kDa, will inhibit the sinusoidal cell uptake of glycoproteins in vitro. | lld:pubmed |
pubmed-article:6086401 | pubmed:language | eng | lld:pubmed |
pubmed-article:6086401 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6086401 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:6086401 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6086401 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6086401 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6086401 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6086401 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6086401 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6086401 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6086401 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6086401 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6086401 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:6086401 | pubmed:month | Jul | lld:pubmed |
pubmed-article:6086401 | pubmed:issn | 0014-5793 | lld:pubmed |
pubmed-article:6086401 | pubmed:author | pubmed-author:SummerfieldJ... | lld:pubmed |
pubmed-article:6086401 | pubmed:author | pubmed-author:TaylorM EME | lld:pubmed |
pubmed-article:6086401 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:6086401 | pubmed:day | 23 | lld:pubmed |
pubmed-article:6086401 | pubmed:volume | 173 | lld:pubmed |
pubmed-article:6086401 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:6086401 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:6086401 | pubmed:pagination | 63-6 | lld:pubmed |
pubmed-article:6086401 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:6086401 | pubmed:meshHeading | pubmed-meshheading:6086401-... | lld:pubmed |
pubmed-article:6086401 | pubmed:meshHeading | pubmed-meshheading:6086401-... | lld:pubmed |
pubmed-article:6086401 | pubmed:meshHeading | pubmed-meshheading:6086401-... | lld:pubmed |
pubmed-article:6086401 | pubmed:meshHeading | pubmed-meshheading:6086401-... | lld:pubmed |
pubmed-article:6086401 | pubmed:meshHeading | pubmed-meshheading:6086401-... | lld:pubmed |
pubmed-article:6086401 | pubmed:meshHeading | pubmed-meshheading:6086401-... | lld:pubmed |
pubmed-article:6086401 | pubmed:meshHeading | pubmed-meshheading:6086401-... | lld:pubmed |
pubmed-article:6086401 | pubmed:meshHeading | pubmed-meshheading:6086401-... | lld:pubmed |
pubmed-article:6086401 | pubmed:meshHeading | pubmed-meshheading:6086401-... | lld:pubmed |
pubmed-article:6086401 | pubmed:meshHeading | pubmed-meshheading:6086401-... | lld:pubmed |
pubmed-article:6086401 | pubmed:meshHeading | pubmed-meshheading:6086401-... | lld:pubmed |
pubmed-article:6086401 | pubmed:meshHeading | pubmed-meshheading:6086401-... | lld:pubmed |
pubmed-article:6086401 | pubmed:meshHeading | pubmed-meshheading:6086401-... | lld:pubmed |
pubmed-article:6086401 | pubmed:meshHeading | pubmed-meshheading:6086401-... | lld:pubmed |
pubmed-article:6086401 | pubmed:meshHeading | pubmed-meshheading:6086401-... | lld:pubmed |
pubmed-article:6086401 | pubmed:meshHeading | pubmed-meshheading:6086401-... | lld:pubmed |
pubmed-article:6086401 | pubmed:year | 1984 | lld:pubmed |
pubmed-article:6086401 | pubmed:articleTitle | Human serum contains a lectin which inhibits hepatic uptake of glycoproteins. | lld:pubmed |
pubmed-article:6086401 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:6086401 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |